AS1404 Lung cancer drug

An experimental lung cancer drug has extended patients' life expectancy by more than 50% in preliminary trials.
Patients given the drug AS1404 on top of standard chemotherapy lived an average of 14 months compared with 8.8 months if given chemotherapy alone.

read more at http://news.bbc.co.uk/1/hi/health/5385726.stm